200 Participants Needed

Quit Smoking Text Messages for Smoking Cessation

KA
Overseen ByKathleen A Garrison, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Yale University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I need to stop my current medications to join the trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the idea that Quit Smoking Text Messages for Smoking Cessation is an effective treatment?

The available research shows that text messaging programs are effective in helping people quit smoking. For example, the SmokefreeTXT program has been shown to improve quitting outcomes in the general population. Additionally, the Quit4baby program, which is a text messaging service for pregnant smokers, has also demonstrated effectiveness. A study comparing text messaging to a smartphone app found that text messaging successfully supported smoking cessation. Overall, these studies suggest that text messaging is a helpful tool for people trying to quit smoking.12345

What safety data is available for the Quit Smoking Text Messages program?

The available research does not directly address safety data for the Quit Smoking Text Messages program. However, the studies on SmokefreeTXT and SmokefreeVET, which are similar text messaging interventions, suggest that these programs are generally safe. The inclusion of suicide prevention referrals in SmokefreeVET indicates a consideration for mental health safety. No specific adverse safety issues are reported in the studies.56789

Is SmokefreeTXT a promising treatment to help people quit smoking?

Yes, SmokefreeTXT is a promising treatment for helping people quit smoking. Research shows that text messaging programs like SmokefreeTXT can effectively support and motivate people to stop smoking by providing advice, support, and reminders.12101112

What is the purpose of this trial?

This project will address research gaps and advance the science of smoking cessation by conducting a randomized controlled trial of an evidence-based, population-level quit smoking text messaging program with or without a smartband.

Research Team

KA

Kathleen A Garrison, PhD

Principal Investigator

Yale University

Eligibility Criteria

This trial is for daily smokers who have been smoking for at least six months and are interested in quitting. It's not open to individuals already enrolled in another quit smoking program.

Inclusion Criteria

Report an interest in quitting smoking.
Daily smokers for at least 6 months

Exclusion Criteria

Reporting being currently enrolled in another quit smoking program

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the SmokefreeTXT program with or without a smartband for smoking cessation

8 weeks

Follow-up

Participants are monitored for smoking cessation outcomes and relapse

2 weeks

Treatment Details

Interventions

  • Smartband
  • SmokefreeTXT
Trial Overview The study is testing the effectiveness of a quit smoking text messaging service called SmokefreeTXT, with some participants also using a smartband. Participants will be randomly placed into groups to receive either just the texts or texts plus the smartband.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: SmokefreeTXT + smartbandExperimental Treatment2 Interventions
Daily smokers for at least 6 months who report an interest in quitting will be randomized to receive the National Cancer Institute's SmokefreeTXT + smartband.
Group II: SmokefreeTXTActive Control1 Intervention
Daily smokers for at least 6 months who report an interest in quitting will be randomized to receive the National Cancer Institute's SmokefreeTXT.

SmokefreeTXT is already approved in United States for the following indications:

🇺🇸
Approved in United States as SmokefreeTXT for:
  • Smoking cessation

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

American Lung Association

Collaborator

Trials
32
Recruited
11,000+

Findings from Research

A text messaging (SMS) program developed for adult smokers in primary care received high ratings for clarity and usefulness, with 96% of messages rated positively by participants.
Patients expressed a desire for personalized messages, inclusion of e-cigarette information, and graphics, while also identifying gaps in knowledge about nicotine replacement therapy (NRT) safety and effectiveness, highlighting the importance of tailoring interventions to meet smokers' needs.
Combining Real-Time Ratings With Qualitative Interviews to Develop a Smoking Cessation Text Messaging Program for Primary Care Patients.Kruse, G., Park, ER., Shahid, NN., et al.[2023]
The pilot test of Quit4baby, a smoking cessation text messaging program for pregnant women, showed that participants found it feasible and acceptable, with positive feedback on its content and support features.
Most participants reported that Quit4baby was helpful in their quitting efforts and expressed a willingness to recommend it to others, indicating potential for further development and testing of its effectiveness in promoting smoking cessation during pregnancy.
Quit4baby: results from a pilot test of a mobile smoking cessation program for pregnant women.Abroms, LC., Johnson, PR., Heminger, CL., et al.[2022]
In a study of 8,487 participants in the SmokefreeTXT program, Black smokers were more likely to complete the program than White smokers, with an adjusted odds ratio of 1.71, indicating higher program retention.
Despite higher completion rates, Black participants were less engaged overall, responding less frequently to assessments and reporting lower abstinence rates, suggesting the need for further research to identify barriers to effective engagement and cessation among Black smokers.
Engagement and Short-term Abstinence Outcomes Among Blacks and Whites in the National Cancer Institute's SmokefreeTXT Program.Robinson, CD., Wiseman, KP., Webb Hooper, M., et al.[2022]

References

Combining Real-Time Ratings With Qualitative Interviews to Develop a Smoking Cessation Text Messaging Program for Primary Care Patients. [2023]
Quit4baby: results from a pilot test of a mobile smoking cessation program for pregnant women. [2022]
Engagement and Short-term Abstinence Outcomes Among Blacks and Whites in the National Cancer Institute's SmokefreeTXT Program. [2022]
Randomized trial of a smartphone mobile application compared to text messaging to support smoking cessation. [2022]
How do smokers use a smoking cessation text messaging intervention? [2018]
Using the text-messaging program SmokefreeTXT to support smoking cessation for nondaily smokers. [2020]
Analysing user-reported data for enhancement of SmokefreeTXT: a national text message smoking cessation intervention. [2018]
Suicide Prevention Referrals in a Mobile Health Smoking Cessation Intervention. [2022]
Engagement and abstinence among users of a smoking cessation text message program for veterans. [2019]
A randomized trial of Text2Quit: a text messaging program for smoking cessation. [2022]
Text messaging-based smoking cessation intervention: a narrative review. [2022]
Quit4hlth: a preliminary investigation of tobacco treatment with gain-framed and loss-framed text messages for quitline callers. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security